ClearPoint Neuro, Inc. (CLPT)
USD 12.14
(-7.3%)
USD 12.14
(-7.3%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 36.06 Million USD | 20.75% |
| 2022 | 29.86 Million USD | 21.07% |
| 2021 | 24.66 Million USD | 60.79% |
| 2020 | 15.34 Million USD | 28.07% |
| 2019 | 11.97 Million USD | 17.8% |
| 2018 | 10.16 Million USD | -6.0% |
| 2017 | 10.81 Million USD | 2.09% |
| 2016 | 10.59 Million USD | 2.59% |
| 2015 | 10.32 Million USD | -8.9% |
| 2014 | 11.33 Million USD | 13.55% |
| 2013 | 9.98 Million USD | 30.82% |
| 2012 | 7.63 Million USD | -15.98% |
| 2011 | 9.08 Million USD | -12.49% |
| 2010 | 10.37 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 9.72 Million USD | 11.09% |
| 2024 Q1 | 8.75 Million USD | 0.42% |
| 2023 Q4 | 8.71 Million USD | 6.72% |
| 2023 Q1 | 8.91 Million USD | 14.5% |
| 2023 Q3 | 8.17 Million USD | -20.35% |
| 2023 Q2 | 10.25 Million USD | 15.07% |
| 2023 FY | 36.06 Million USD | 20.75% |
| 2022 Q3 | 7.5 Million USD | 0.62% |
| 2022 Q4 | 7.78 Million USD | 3.7% |
| 2022 Q1 | 7.11 Million USD | -2.21% |
| 2022 Q2 | 7.46 Million USD | 4.94% |
| 2022 FY | 29.86 Million USD | 21.07% |
| 2021 Q2 | 5.69 Million USD | 18.81% |
| 2021 FY | 24.66 Million USD | 60.79% |
| 2021 Q4 | 7.27 Million USD | 5.5% |
| 2021 Q1 | 4.79 Million USD | 5.41% |
| 2021 Q3 | 6.89 Million USD | 20.98% |
| 2020 Q2 | 3.31 Million USD | -2.78% |
| 2020 Q1 | 3.4 Million USD | -7.87% |
| 2020 Q4 | 4.54 Million USD | 11.72% |
| 2020 Q3 | 4.07 Million USD | 22.95% |
| 2020 FY | 15.34 Million USD | 28.07% |
| 2019 Q3 | 2.85 Million USD | -0.49% |
| 2019 Q4 | 3.69 Million USD | 29.51% |
| 2019 FY | 11.97 Million USD | 17.8% |
| 2019 Q1 | 2.55 Million USD | -0.32% |
| 2019 Q2 | 2.86 Million USD | 12.15% |
| 2018 Q2 | 2.68 Million USD | 8.88% |
| 2018 FY | 10.16 Million USD | -6.0% |
| 2018 Q4 | 2.56 Million USD | 4.33% |
| 2018 Q1 | 2.46 Million USD | -13.73% |
| 2018 Q3 | 2.46 Million USD | -8.21% |
| 2017 Q3 | 2.35 Million USD | -21.48% |
| 2017 FY | 10.81 Million USD | 2.09% |
| 2017 Q1 | 2.6 Million USD | -5.1% |
| 2017 Q2 | 2.99 Million USD | 15.01% |
| 2017 Q4 | 2.85 Million USD | 21.13% |
| 2016 Q3 | 2.57 Million USD | -2.29% |
| 2016 Q2 | 2.63 Million USD | 0.25% |
| 2016 Q1 | 2.63 Million USD | 15.19% |
| 2016 FY | 10.59 Million USD | 2.59% |
| 2016 Q4 | 2.74 Million USD | 6.63% |
| 2015 FY | 10.32 Million USD | -8.9% |
| 2015 Q4 | 2.28 Million USD | -12.57% |
| 2015 Q3 | 2.61 Million USD | -0.05% |
| 2015 Q2 | 2.61 Million USD | -7.17% |
| 2015 Q1 | 2.81 Million USD | -4.7% |
| 2014 Q3 | 2.93 Million USD | 3.82% |
| 2014 Q1 | 2.61 Million USD | -3.42% |
| 2014 Q4 | 2.95 Million USD | 0.66% |
| 2014 FY | 11.33 Million USD | 13.55% |
| 2014 Q2 | 2.82 Million USD | 7.99% |
| 2013 Q4 | 2.71 Million USD | 11.88% |
| 2013 FY | 9.98 Million USD | 30.82% |
| 2013 Q1 | 2.4 Million USD | 10.32% |
| 2013 Q2 | 2.44 Million USD | 1.67% |
| 2013 Q3 | 2.42 Million USD | -0.89% |
| 2012 Q4 | 2.18 Million USD | 8.16% |
| 2012 Q2 | 2.28 Million USD | 12.77% |
| 2012 Q1 | 2.02 Million USD | -9.41% |
| 2012 FY | 7.63 Million USD | -15.98% |
| 2012 Q3 | 2.01 Million USD | -11.95% |
| 2011 FY | 9.08 Million USD | -12.49% |
| 2011 Q3 | 2.27 Million USD | 5.22% |
| 2011 Q4 | 2.24 Million USD | -1.63% |
| 2011 Q2 | 2.16 Million USD | 0.0% |
| 2010 FY | 10.37 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -221.276% |
| Cerus Corporation | 143.15 Million USD | 74.811% |
| OrthoPediatrics Corp. | 137.01 Million USD | 73.682% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -217.405% |
| Talis Biomedical Corporation | 67.18 Million USD | 46.328% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -44.552% |
| Inogen, Inc. | 236.08 Million USD | 84.726% |
| Spectral AI, Inc. | 20.86 Million USD | -72.834% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 35.604% |
| CVRx, Inc. | 76.14 Million USD | 52.641% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -922.11% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -188.734% |
| Orthofix Medical Inc. | 667.42 Million USD | 94.597% |
| Venus Concept Inc. | 80.47 Million USD | 55.192% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 36.265% |
| Bioventus Inc. | 409.91 Million USD | 91.203% |
| BrainsWay Ltd. | 28.01 Million USD | -28.703% |
| Envoy Medical, Inc. | 17.89 Million USD | -101.475% |
| electroCore, Inc. | 32.03 Million USD | -12.578% |
| IceCure Medical Ltd | 16.87 Million USD | -113.676% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 15.017% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -104.503% |
| MaxCyte, Inc. | 84.84 Million USD | 57.499% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -190.531% |
| Nexalin Technology, Inc. | 5.78 Million USD | -523.729% |
| PAVmed Inc | 64.82 Million USD | 44.375% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 29.402% |
| RxSight, Inc. | 103.85 Million USD | 65.277% |
| Sight Sciences, Inc. | 126.44 Million USD | 71.483% |
| SI-BONE, Inc. | 156.35 Million USD | 76.937% |
| TELA Bio, Inc. | 84.18 Million USD | 57.167% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 48.527% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 82.268% |
| LivaNova PLC | 843.54 Million USD | 95.725% |
| 908 Devices Inc. | 68.08 Million USD | 47.033% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 92.543% |
| Nemaura Medical Inc. | 7.13 Million USD | -405.127% |
| NeuroPace, Inc. | 75.29 Million USD | 52.109% |
| LENSAR, Inc. | 33.33 Million USD | -8.171% |
| Apyx Medical Corporation | 51.01 Million USD | 29.319% |
| Cutera, Inc. | 197.72 Million USD | 81.762% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -45.515% |
| BioSig Technologies, Inc. | 28.53 Million USD | -26.393% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 81.167% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 95.689% |
| Axonics, Inc. | 270.2 Million USD | 86.654% |
| Outset Medical, Inc. | 198.77 Million USD | 81.858% |
| IRIDEX Corporation | 31.81 Million USD | -13.346% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 79.991% |
| IRadimed Corporation | 30.12 Million USD | -19.71% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -322.644% |
| INVO Bioscience, Inc. | 7.85 Million USD | -359.17% |
| Telesis Bio, Inc. | 63.48 Million USD | 43.203% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 63.373% |
| Varex Imaging Corporation | 224.8 Million USD | 83.959% |
| Quipt Home Medical Corp. | 148.66 Million USD | 75.744% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -207.6% |
| Pulmonx Corporation | 112.68 Million USD | 68.0% |
| Dynatronics Corporation | 9.9 Million USD | -263.947% |
| Modular Medical, Inc. | 17.52 Million USD | -105.716% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -78.63% |
| Semler Scientific, Inc. | 38.94 Million USD | 7.406% |
| InMode Ltd. | 215.68 Million USD | 83.281% |
| Bruker Corporation | 1.07 Billion USD | 96.65% |
| Cytosorbents Corporation | 48.33 Million USD | 25.399% |
| DexCom, Inc. | 1.69 Billion USD | 97.868% |
| Align Technology, Inc. | 2.07 Billion USD | 98.264% |
| Viveve Medical, Inc. | 22.17 Million USD | -62.63% |
| ZimVie Inc. | 275.12 Million USD | 86.893% |
| Movano Inc. | 29.69 Million USD | -21.455% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 73.731% |
| Nexalin Technology, Inc. | 5.78 Million USD | -523.729% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -922.11% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 93.999% |
| Profound Medical Corp. | 33.6 Million USD | -7.311% |
| Insulet Corporation | 939.9 Million USD | 96.163% |
| enVVeno Medical Corporation | 25.23 Million USD | -42.88% |
| Surmodics, Inc. | 98.69 Million USD | 63.464% |
| iCAD, Inc. | 22.22 Million USD | -62.25% |
| Nuwellis, Inc. | 22.61 Million USD | -59.466% |
| Biotricity, Inc. | 17.18 Million USD | -109.84% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 91.913% |
| Aethlon Medical, Inc. | 12.27 Million USD | -193.708% |
| InspireMD, Inc. | 22.95 Million USD | -57.124% |
| PAVmed Inc. | 64.82 Million USD | 44.375% |
| BIOLASE, Inc. | 34.66 Million USD | -4.036% |
| Beyond Air, Inc. | 61.7 Million USD | 41.556% |
| FONAR Corporation | 28.6 Million USD | -26.063% |
| AxoGen, Inc. | 149.33 Million USD | 75.853% |
| Vivani Medical, Inc. | 26.96 Million USD | -33.729% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 79.638% |
| Inari Medical, Inc. | 448.59 Million USD | 91.962% |
| UFP Technologies, Inc. | 58.08 Million USD | 37.923% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -631.797% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -470.724% |
| Tenon Medical, Inc. | 16.96 Million USD | -112.518% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -387.759% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 18.237% |
| AdaptHealth Corp. | 1.07 Billion USD | 96.655% |
| Sintx Technologies, Inc. | 15.2 Million USD | -137.221% |
| NanoVibronix, Inc. | 4.97 Million USD | -625.116% |
| Quanterix Corporation | 118.1 Million USD | 69.467% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -207.6% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -149.688% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 90.817% |
| TransMedics Group, Inc. | 182.82 Million USD | 80.276% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -28.487% |
| NeuroMetrix, Inc. | 11.09 Million USD | -224.896% |
| Hyperfine, Inc. | 52.87 Million USD | 31.798% |
| Establishment Labs Holdings Inc. | 172 Million USD | 79.035% |
| Biomerica, Inc. | 6.97 Million USD | -416.767% |
| Bone Biologics Corporation | 9.42 Million USD | -282.465% |
| AVITA Medical, Inc. | 80.77 Million USD | 55.36% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -249.716% |
| Silk Road Medical, Inc | 186.35 Million USD | 80.65% |